Global Endoparasiticide Market Growth 2020-2025

Global Endoparasiticide Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Endoparasiticide Consumption 2015-2025
2.1.2 Endoparasiticide Consumption CAGR by Region
2.2 Endoparasiticide Segment by Type
2.2.1 Ear Tags
2.2.2 Tablets
2.2.3 Injectables
2.2.4 Feed Additives
2.3 Endoparasiticide Consumption by Type
2.3.1 Global Endoparasiticide Consumption Market Share by Type (2015-2020)
2.3.2 Global Endoparasiticide Revenue and Market Share by Type (2015-2020)
2.3.3 Global Endoparasiticide Sale Price by Type (2015-2020)
2.4 Endoparasiticide Segment by Application
2.4.1 Veterinary Hospitals or Clinics
2.4.2 Animal Farms
2.4.3 Home Care Settings
2.5 Endoparasiticide Consumption by Application
2.5.1 Global Endoparasiticide Consumption Market Share by Type (2015-2020)
2.5.2 Global Endoparasiticide Value and Market Share by Type (2015-2020)
2.5.3 Global Endoparasiticide Sale Price by Type (2015-2020)

3 Global Endoparasiticide by Company
3.1 Global Endoparasiticide Sales Market Share by Company
3.1.1 Global Endoparasiticide Sales by Company (2018-2020)
3.1.2 Global Endoparasiticide Sales Market Share by Company (2018-2020)
3.2 Global Endoparasiticide Revenue Market Share by Company
3.2.1 Global Endoparasiticide Revenue by Company (2018-2020)
3.2.2 Global Endoparasiticide Revenue Market Share by Company (2018-2020)
3.3 Global Endoparasiticide Sale Price by Company
3.4 Global Endoparasiticide Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Endoparasiticide Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Endoparasiticide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Endoparasiticide by Regions
4.1 Endoparasiticide by Regions
4.2 Americas Endoparasiticide Consumption Growth
4.3 APAC Endoparasiticide Consumption Growth
4.4 Europe Endoparasiticide Consumption Growth
4.5 Middle East & Africa Endoparasiticide Consumption Growth

5 Americas
5.1 Americas Endoparasiticide Consumption by Countries
5.1.1 Americas Endoparasiticide Consumption by Countries (2015-2020)
5.1.2 Americas Endoparasiticide Value by Countries (2015-2020)
5.2 Americas Endoparasiticide Consumption by Type
5.3 Americas Endoparasiticide Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Endoparasiticide Consumption by Regions
6.1.1 APAC Endoparasiticide Consumption by Regions (2015-2020)
6.1.2 APAC Endoparasiticide Value by Regions (2015-2020)
6.2 APAC Endoparasiticide Consumption by Type
6.3 APAC Endoparasiticide Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Endoparasiticide by Countries
7.1.1 Europe Endoparasiticide Consumption by Countries (2015-2020)
7.1.2 Europe Endoparasiticide Value by Countries (2015-2020)
7.2 Europe Endoparasiticide Consumption by Type
7.3 Europe Endoparasiticide Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Endoparasiticide by Countries
8.1.1 Middle East & Africa Endoparasiticide Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Endoparasiticide Value by Countries (2015-2020)
8.2 Middle East & Africa Endoparasiticide Consumption by Type
8.3 Middle East & Africa Endoparasiticide Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Endoparasiticide Distributors
10.3 Endoparasiticide Customer

11 Global Endoparasiticide Market Forecast
11.1 Global Endoparasiticide Consumption Forecast (2021-2025)
11.2 Global Endoparasiticide Forecast by Regions
11.2.1 Global Endoparasiticide Forecast by Regions (2021-2025)
11.2.2 Global Endoparasiticide Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Endoparasiticide Forecast by Type
11.8 Global Endoparasiticide Forecast by Application

12 Key Players Analysis
12.1 Boehringer Ingelheim
12.1.1 Company Information
12.1.2 Endoparasiticide Product Offered
12.1.3 Boehringer Ingelheim Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Boehringer Ingelheim Latest Developments
12.2 Vetoquinol
12.2.1 Company Information
12.2.2 Endoparasiticide Product Offered
12.2.3 Vetoquinol Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Vetoquinol Latest Developments
12.3 Elanco
12.3.1 Company Information
12.3.2 Endoparasiticide Product Offered
12.3.3 Elanco Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Elanco Latest Developments
12.4 Merck
12.4.1 Company Information
12.4.2 Endoparasiticide Product Offered
12.4.3 Merck Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Merck Latest Developments
12.5 Virbac
12.5.1 Company Information
12.5.2 Endoparasiticide Product Offered
12.5.3 Virbac Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Virbac Latest Developments
12.6 Zoetis
12.6.1 Company Information
12.6.2 Endoparasiticide Product Offered
12.6.3 Zoetis Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Zoetis Latest Developments
12.7 Bayer AG
12.7.1 Company Information
12.7.2 Endoparasiticide Product Offered
12.7.3 Bayer AG Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Bayer AG Latest Developments
12.8 Novartis AG
12.8.1 Company Information
12.8.2 Endoparasiticide Product Offered
12.8.3 Novartis AG Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Novartis AG Latest Developments
12.9 Eli Lilly
12.9.1 Company Information
12.9.2 Endoparasiticide Product Offered
12.9.3 Eli Lilly Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Eli Lilly Latest Developments
12.10 Ceva Sante Animlae
12.10.1 Company Information
12.10.2 Endoparasiticide Product Offered
12.10.3 Ceva Sante Animlae Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Ceva Sante Animlae Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Endoparasiticide Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Ear Tags
Table 5. Major Players of Tablets
Table 6. Major Players of Injectables
Table 7. Major Players of Feed Additives
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Endoparasiticide Consumption Market Share by Type (2015-2020)
Table 10. Global Endoparasiticide Revenue by Type (2015-2020) ($ million)
Table 11. Global Endoparasiticide Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Endoparasiticide Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Endoparasiticide Consumption Market Share by Application (2015-2020)
Table 15. Global Endoparasiticide Value by Application (2015-2020)
Table 16. Global Endoparasiticide Value Market Share by Application (2015-2020)
Table 17. Global Endoparasiticide Sale Price by Application (2015-2020)
Table 18. Global Endoparasiticide Sales by Company (2017-2019) (K Units)
Table 19. Global Endoparasiticide Sales Market Share by Company (2017-2019)
Table 20. Global Endoparasiticide Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Endoparasiticide Revenue Market Share by Company (2017-2019)
Table 22. Global Endoparasiticide Sale Price by Company (2017-2019)
Table 23. Global Endoparasiticide Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Endoparasiticide Products Offered
Table 25. Endoparasiticide Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Endoparasiticide Consumption by Regions 2015-2020 (K Units)
Table 27. Global Endoparasiticide Consumption Market Share by Regions 2015-2020
Table 28. Global Endoparasiticide Value by Regions 2015-2020 ($ Millions)
Table 29. Global Endoparasiticide Value Market Share by Regions 2015-2020
Table 30. Americas Endoparasiticide Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Endoparasiticide Consumption Market Share by Countries (2015-2020)
Table 32. Americas Endoparasiticide Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Endoparasiticide Value Market Share by Countries (2015-2020)
Table 34. Americas Endoparasiticide Consumption by Type (2015-2020) (K Units)
Table 35. Americas Endoparasiticide Consumption Market Share by Type (2015-2020)
Table 36. Americas Endoparasiticide Consumption by Application (2015-2020) (K Units)
Table 37. Americas Endoparasiticide Consumption Market Share by Application (2015-2020)
Table 38. APAC Endoparasiticide Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Endoparasiticide Consumption Market Share by Countries (2015-2020)
Table 40. APAC Endoparasiticide Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Endoparasiticide Value Market Share by Regions (2015-2020)
Table 42. APAC Endoparasiticide Consumption by Type (2015-2020) (K Units)
Table 43. APAC Endoparasiticide Consumption Market Share by Type (2015-2020)
Table 44. APAC Endoparasiticide Consumption by Application (2015-2020) (K Units)
Table 45. APAC Endoparasiticide Consumption Market Share by Application (2015-2020)
Table 46. Europe Endoparasiticide Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Endoparasiticide Consumption Market Share by Countries (2015-2020)
Table 48. Europe Endoparasiticide Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Endoparasiticide Value Market Share by Countries (2015-2020)
Table 50. Europe Endoparasiticide Consumption by Type (2015-2020) (K Units)
Table 51. Europe Endoparasiticide Consumption Market Share by Type (2015-2020)
Table 52. Europe Endoparasiticide Consumption by Application (2015-2020) (K Units)
Table 53. Europe Endoparasiticide Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Endoparasiticide Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Endoparasiticide Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Endoparasiticide Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Endoparasiticide Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Endoparasiticide Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Endoparasiticide Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Endoparasiticide Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Endoparasiticide Consumption Market Share by Application (2015-2020)
Table 62. Endoparasiticide Distributors List
Table 63. Endoparasiticide Customer List
Table 64. Global Endoparasiticide Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Endoparasiticide Consumption Market Forecast by Regions
Table 66. Global Endoparasiticide Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Endoparasiticide Value Market Share Forecast by Regions
Table 68. Global Endoparasiticide Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Endoparasiticide Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Endoparasiticide Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Endoparasiticide Value Market Share Forecast by Type (2021-2025)
Table 72. Global Endoparasiticide Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Endoparasiticide Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Endoparasiticide Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Endoparasiticide Value Market Share Forecast by Application (2021-2025)
Table 76. Boehringer Ingelheim Product Offered
Table 77. Boehringer Ingelheim Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. Boehringer Ingelheim Main Business
Table 79. Boehringer Ingelheim Latest Developments
Table 80. Boehringer Ingelheim Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 81. Vetoquinol Product Offered
Table 82. Vetoquinol Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. Vetoquinol Main Business
Table 84. Vetoquinol Latest Developments
Table 85. Vetoquinol Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 86. Elanco Product Offered
Table 87. Elanco Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. Elanco Main Business
Table 89. Elanco Latest Developments
Table 90. Elanco Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck Product Offered
Table 92. Merck Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Merck Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 96. Virbac Product Offered
Table 97. Virbac Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Virbac Main Business
Table 99. Virbac Latest Developments
Table 100. Virbac Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 101. Zoetis Product Offered
Table 102. Zoetis Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. Zoetis Main Business
Table 104. Zoetis Latest Developments
Table 105. Zoetis Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 106. Bayer AG Product Offered
Table 107. Bayer AG Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 108. Bayer AG Main Business
Table 109. Bayer AG Latest Developments
Table 110. Bayer AG Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Novartis AG Product Offered
Table 112. Novartis AG Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Novartis AG Main Business
Table 114. Novartis AG Latest Developments
Table 115. Novartis AG Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 116. Eli Lilly Product Offered
Table 117. Eli Lilly Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 118. Eli Lilly Main Business
Table 119. Eli Lilly Latest Developments
Table 120. Eli Lilly Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 121. Ceva Sante Animlae Product Offered
Table 122. Ceva Sante Animlae Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 123. Ceva Sante Animlae Main Business
Table 124. Ceva Sante Animlae Latest Developments
Table 125. Ceva Sante Animlae Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Endoparasiticide
Figure 2. Endoparasiticide Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Endoparasiticide Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Endoparasiticide Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Ear Tags
Figure 7. Product Picture of Tablets
Figure 8. Product Picture of Injectables
Figure 9. Product Picture of Feed Additives
Figure 10. Global Endoparasiticide Consumption Market Share by Type (2015-2020)
Figure 11. Global Endoparasiticide Value Market Share by Type (2015-2020)
Figure 12. Endoparasiticide Consumed in Veterinary Hospitals or Clinics
Figure 13. Global Endoparasiticide Market: Veterinary Hospitals or Clinics (2015-2020) (K Units)
Figure 14. Global Endoparasiticide Market: Veterinary Hospitals or Clinics (2015-2020) ($ Millions)
Figure 15. Endoparasiticide Consumed in Animal Farms
Figure 16. Global Endoparasiticide Market: Animal Farms (2015-2020) (K Units)
Figure 17. Global Endoparasiticide Market: Animal Farms (2015-2020) ($ Millions)
Figure 18. Endoparasiticide Consumed in Home Care Settings
Figure 19. Global Endoparasiticide Market: Home Care Settings (2015-2020) (K Units)
Figure 20. Global Endoparasiticide Market: Home Care Settings (2015-2020) ($ Millions)
Figure 21. Global Endoparasiticide Consumption Market Share by Application (2015-2020)
Figure 22. Global Endoparasiticide Value Market Share by Application (2015-2020)
Figure 23. Global Endoparasiticide Sales Market Share by Company in 2017
Figure 24. Global Endoparasiticide Sales Market Share by Company in 2019
Figure 25. Global Endoparasiticide Revenue Market Share by Company in 2017
Figure 26. Global Endoparasiticide Revenue Market Share by Company in 2019
Figure 27. Global Endoparasiticide Sale Price by Company in 2019
Figure 28. Global Endoparasiticide Consumption Market Share by Regions 2015-2020
Figure 29. Global Endoparasiticide Value Market Share by Regions 2015-2020
Figure 30. Americas Endoparasiticide Consumption 2015-2020 (K Units)
Figure 31. Americas Endoparasiticide Value 2015-2020 ($ Millions)
Figure 32. APAC Endoparasiticide Consumption 2015-2020 (K Units)
Figure 33. APAC Endoparasiticide Value 2015-2020 ($ Millions)
Figure 34. Europe Endoparasiticide Consumption 2015-2020 (K Units)
Figure 35. Europe Endoparasiticide Value 2015-2020 ($ Millions)
Figure 36. Middle East & Africa Endoparasiticide Consumption 2015-2020 (K Units)
Figure 37. Middle East & Africa Endoparasiticide Value 2015-2020 ($ Millions)
Figure 38. Americas Endoparasiticide Consumption Market Share by Countries in 2019
Figure 39. Americas Endoparasiticide Value Market Share by Countries in 2019
Figure 40. Americas Endoparasiticide Consumption Market Share by Type in 2019
Figure 41. Americas Endoparasiticide Consumption Market Share by Application in 2019
Figure 42. United States Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 43. United States Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 44. Canada Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 45. Canada Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 46. Mexico Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 47. Mexico Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 48. APAC Endoparasiticide Consumption Market Share by Countries in 2019
Figure 49. APAC Endoparasiticide Value Market Share by Regions in 2019
Figure 50. APAC Endoparasiticide Consumption Market Share by Type in 2019
Figure 51. APAC Endoparasiticide Consumption Market Share by Application in 2019
Figure 52. China Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 53. China Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 54. Japan Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 55. Japan Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 56. Korea Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 57. Korea Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 58. Southeast Asia Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 59. Southeast Asia Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 60. India Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 61. India Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 62. Australia Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 63. Australia Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 64. Europe Endoparasiticide Consumption Market Share by Countries in 2019
Figure 65. Europe Endoparasiticide Value Market Share by Countries in 2019
Figure 66. Europe Endoparasiticide Consumption Market Share by Type in 2019
Figure 67. Europe Endoparasiticide Consumption Market Share by Application in 2019
Figure 68. Germany Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 69. Germany Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 70. France Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 71. France Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 72. UK Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 73. UK Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 74. Italy Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 75. Italy Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 76. Russia Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 77. Russia Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 78. Middle East & Africa Endoparasiticide Consumption Market Share by Countries in 2019
Figure 79. Middle East & Africa Endoparasiticide Value Market Share by Countries in 2019
Figure 80. Middle East & Africa Endoparasiticide Consumption Market Share by Type in 2019
Figure 81. Middle East & Africa Endoparasiticide Consumption Market Share by Application in 2019
Figure 82. Egypt Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 83. Egypt Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 84. South Africa Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 85. South Africa Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 86. Israel Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 87. Israel Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 88. Turkey Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 89. Turkey Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 90. GCC Countries Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 91. GCC Countries Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 92. Global Endoparasiticide Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 93. Global Endoparasiticide Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 94. Americas Endoparasiticide Consumption 2021-2025 (K Units)
Figure 95. Americas Endoparasiticide Value 2021-2025 ($ Millions)
Figure 96. APAC Endoparasiticide Consumption 2021-2025 (K Units)
Figure 97. APAC Endoparasiticide Value 2021-2025 ($ Millions)
Figure 98. Europe Endoparasiticide Consumption 2021-2025 (K Units)
Figure 99. Europe Endoparasiticide Value 2021-2025 ($ Millions)
Figure 100. Middle East & Africa Endoparasiticide Consumption 2021-2025 (K Units)
Figure 101. Middle East & Africa Endoparasiticide Value 2021-2025 ($ Millions)
Figure 102. United States Endoparasiticide Consumption 2021-2025 (K Units)
Figure 103. United States Endoparasiticide Value 2021-2025 ($ Millions)
Figure 104. Canada Endoparasiticide Consumption 2021-2025 (K Units)
Figure 105. Canada Endoparasiticide Value 2021-2025 ($ Millions)
Figure 106. Mexico Endoparasiticide Consumption 2021-2025 (K Units)
Figure 107. Mexico Endoparasiticide Value 2021-2025 ($ Millions)
Figure 108. Brazil Endoparasiticide Consumption 2021-2025 (K Units)
Figure 109. Brazil Endoparasiticide Value 2021-2025 ($ Millions)
Figure 110. China Endoparasiticide Consumption 2021-2025 (K Units)
Figure 111. China Endoparasiticide Value 2021-2025 ($ Millions)
Figure 112. Japan Endoparasiticide Consumption 2021-2025 (K Units)
Figure 113. Japan Endoparasiticide Value 2021-2025 ($ Millions)
Figure 114. Korea Endoparasiticide Consumption 2021-2025 (K Units)
Figure 115. Korea Endoparasiticide Value 2021-2025 ($ Millions)
Figure 116. Southeast Asia Endoparasiticide Consumption 2021-2025 (K Units)
Figure 117. Southeast Asia Endoparasiticide Value 2021-2025 ($ Millions)
Figure 118. India Endoparasiticide Consumption 2021-2025 (K Units)
Figure 119. India Endoparasiticide Value 2021-2025 ($ Millions)
Figure 120. Australia Endoparasiticide Consumption 2021-2025 (K Units)
Figure 121. Australia Endoparasiticide Value 2021-2025 ($ Millions)
Figure 122. Germany Endoparasiticide Consumption 2021-2025 (K Units)
Figure 123. Germany Endoparasiticide Value 2021-2025 ($ Millions)
Figure 124. France Endoparasiticide Consumption 2021-2025 (K Units)
Figure 125. France Endoparasiticide Value 2021-2025 ($ Millions)
Figure 126. UK Endoparasiticide Consumption 2021-2025 (K Units)
Figure 127. UK Endoparasiticide Value 2021-2025 ($ Millions)
Figure 128. Italy Endoparasiticide Consumption 2021-2025 (K Units)
Figure 129. Italy Endoparasiticide Value 2021-2025 ($ Millions)
Figure 130. Russia Endoparasiticide Consumption 2021-2025 (K Units)
Figure 131. Russia Endoparasiticide Value 2021-2025 ($ Millions)
Figure 132. Spain Endoparasiticide Consumption 2021-2025 (K Units)
Figure 133. Spain Endoparasiticide Value 2021-2025 ($ Millions)
Figure 134. Egypt Endoparasiticide Consumption 2021-2025 (K Units)
Figure 135. Egypt Endoparasiticide Value 2021-2025 ($ Millions)
Figure 136. South Africa Endoparasiticide Consumption 2021-2025 (K Units)
Figure 137. South Africa Endoparasiticide Value 2021-2025 ($ Millions)
Figure 138. Israel Endoparasiticide Consumption 2021-2025 (K Units)
Figure 139. Israel Endoparasiticide Value 2021-2025 ($ Millions)
Figure 140. Turkey Endoparasiticide Consumption 2021-2025 (K Units)
Figure 141. Turkey Endoparasiticide Value 2021-2025 ($ Millions)
Figure 142. GCC Countries Endoparasiticide Consumption 2021-2025 (K Units)
Figure 143. GCC Countries Endoparasiticide Value 2021-2025 ($ Millions)
Figure 144. Boehringer Ingelheim Endoparasiticide Market Share (2018-2020)
Figure 145. Vetoquinol Endoparasiticide Market Share (2018-2020)
Figure 146. Elanco Endoparasiticide Market Share (2018-2020)
Figure 147. Merck Endoparasiticide Market Share (2018-2020)
Figure 148. Virbac Endoparasiticide Market Share (2018-2020)
Figure 149. Zoetis Endoparasiticide Market Share (2018-2020)
Figure 150. Bayer AG Endoparasiticide Market Share (2018-2020)
Figure 151. Novartis AG Endoparasiticide Market Share (2018-2020)
Figure 152. Eli Lilly Endoparasiticide Market Share (2018-2020)
Figure 153. Ceva Sante Animlae Endoparasiticide Market Share (2018-2020)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs